Sign up
Quantellect · Congress · Trade Detail
NASDAQ: REGNRegeneron Pharmaceuticals Inc
DemocratHouse

Donald S. Beyer, Jr. bought Regeneron Pharmaceuticals Inc (NASDAQ: REGN)

Donald S. Beyer, Jr. (D-VA), a U.S. Representative, has disclosed 7 trades in Regeneron Pharmaceuticals Inc (REGN) since 2020, 4 purchases and 3 sales, worth an estimated $56K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Donald S. Beyer, Jr. bought $1,001 - $15,000 of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) on September 17, 2021. Since that trade, REGN is up +7.56% against the S&P 500 up +75.81%, an outperformance of -68.25%.

Across these filings, Donald S. Beyer, Jr. has been a net buyer of REGN (a buy-to-sell ratio of 1.33). The most recent disclosed REGN transaction shown was dated February 28, 2022. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

REGN trades
7
Disclosed Vol
$56K
Buys
4
57%
Sells
3
43%
Buy / Sell
1.33
ratio
First → Last
2020–2022

Donald S. Beyer, Jr.'s REGN trades vs the price

REGN is up +7.56% since Donald S. Beyer, Jr. bought on September 17, 2021, versus +75.81% for the S&P 500.

Performance since this trade

Price change since trade
+7.56%
S&P 500 change since trade
+75.81%
Outperformance vs S&P 500
-68.25%

All Donald S. Beyer, Jr. REGN trades

TradedTypeSizeReturnEst. profit
February 28, 2022SELL$613.29+13.39%
September 17, 2021BUY$646.54+7.56%+$534
July 21, 2021BUY$578.94+20.12%+$2K
June 17, 2021BUY$531.62+30.81%+$2K
August 14, 2020SELL$607.55+14.46%
July 10, 2020SELL$615.77+12.93%
May 20, 2020BUY$572.16+21.54%+$2K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Donald S. Beyer, Jr. & REGN trading FAQ

Is it legal for Donald S. Beyer, Jr. to trade Regeneron Pharmaceuticals Inc (REGN) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Regeneron Pharmaceuticals Inc (REGN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Donald S. Beyer, Jr. buy REGN?

Donald S. Beyer, Jr. disclosed a purchase of $1,001 - $15,000 of Regeneron Pharmaceuticals Inc (REGN) on September 17, 2021, according to public STOCK Act filings.

How has REGN performed since Donald S. Beyer, Jr.'s trade?

Since Donald S. Beyer, Jr. bought REGN on September 17, 2021, the stock is up +7.56%, versus +75.81% for the S&P 500 over the same period, an outperformance of -68.25%.

How many times has Donald S. Beyer, Jr. traded REGN?

Donald S. Beyer, Jr. has disclosed 7 REGN trades since 2020 (4 purchases and 3 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional REGN trades?

Quantellect tracks every disclosed congressional trade in Regeneron Pharmaceuticals Inc (REGN) on the Regeneron Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.

Donald S. Beyer, Jr.'s REGN tradesAll congressional filings for Regeneron Pharmaceuticals IncDonald S. Beyer, Jr.'s full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.